About Joseph Amprey III
Joseph Amprey III is CEO and director at Zero Point Five Therapeutics.
Joseph Amprey III first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Joseph Amprey III in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Joseph Amprey III works with at each company, as listed on that company's latest Form D.
Zero Point Five Therapeutics, Inc. · Form D, Apr 17, 2025
BA
Ben Auspitz
Director
JJ
Jodi Jahic
Director